Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Bo Jesper Hansen
Age : 63
Public asset : 374,520 USD
Linked companies : Karo Pharma AB (publ) - Ascelia Pharma AB (publ) - Orphazyme A/S
Summary 
Founder of Scandinavian Medical Research, Bo Jesper Hansen is a Danish businessperson who has been at the helm of 12 different companies and presently occupies the position of Chairman of Innoventa Medica ApS, Venture Partner at Wellington Partners GmbH and Chairman at Karo Pharma AB.

He is also on the board of 6 other companies.

Bo Jesper Hansen previously was Chairman at 2941881 Canada, Inc., Chairman at Swedish Orphan Biovitrum AB Chairman of Biovitrum AB, President, Chief Executive Officer & Director at Swedish Orphan Biovitrum International AB and President & Chief Executive Officer of Swedish Orphan International Holding AB (which are all subsidiaries of Swedish Orphan Biovitrum AB), Chairman for Reapplix A, Chairman of Karolinska Development AB and Chairman of Karolinska Development AB (Private Equity) (a subsidiary of Karolinska Development AB), Medical Advisor at SynthÚlabo Scandinavia A, Medical Advisor at Yamanouchi Nordic, Executive Chairman at Topotarget A, Chairman of Ablynx NV, Medical Advisor at Pfizer ApS and Director-Supervisory Board at Novagali Pharma SA.

Dr. Hansen received a doctorate from the University of Copenhagen.


Current positions of Bo Jesper Hansen 
NameTitle Since
Karo Pharma AB (publ)
(Pharmaceuticals)
Chairman 2019
Ascelia Pharma AB (publ)
(Biotechnology & Medical Research)
Independent Director 2010
Orphazyme A/S
(Biotechnology & Medical Research)
Deputy Chairman 2017
Innoventa Medica ApS Chairman -
Reapplix A/S Director -
MipSalus ApS Director -
Amylon Therapeutics BV Member-Supervisory Board -
CMC Sweden AB Director -
Wellington Partners GmbH Venture Partner -


Holdings of Bo Jesper Hansen 
NameEquities%Valuation
Orphazyme A/S (ORPHA)
(Biotechnology & Medical Research)
143,2340.41%374,520 USD


Bo Jesper Hansen: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
08:14aELON MUSK : human-like robots and self-driving cars
RE
01:41pBERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
Bo Jesper Hansen : Connections